FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and relates to a pharmaceutical composition for the treatment of a proliferative disease in a subject, comprising nanoparticles containing albumin and paclitaxel, in which no more than about 2.4% of said albumin in the pharmaceutical composition is in the form of polymers. Group of inventions also relates to a method of treating cancer in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition.
EFFECT: group of inventions provides an albumin polymer/monomer profile, most suitable for use in the treatment of cancer.
31 cl, 5 ex, 9 tbl
